DNA adduct level in lung tissue may act as a risk biomarker of lung cancer

Author： Cheng Y.-W.   Chen C.-Y.   Lin P.   Chen C.-P.   Huang K.H.   Lin T.-S.   Wu M.-H.   Lee H.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.36, Iss.11, 2000-07, pp. : 1381-1388

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Circulating cell-free DNA: a potential biomarker in lung cancer

By Taylor Fiona   Teare M Dawn   Cox Angela   Woll Penella J  

Lung Cancer Management, Vol. 2, Iss. 5, 2013-10 ,pp. : 407-422

Future Medicine

Access to resources Recommend Favorite

Inflammatory response-altering gene variations may raise lung cancer risk

By  

Future Oncology, Vol. 3, Iss. 4, 2007-08 ,pp. : 371-373

Future Medicine

Access to resources Recommend Favorite

Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer

By Zhang Cong   Ye Leiguang   Guan Songlei   Jin Shunzi   Wang Weili   Sun Shilong   Lee Kuang-Hui   Wei Jun   Liu Baogang  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2047-2051

Springer Publishing Company

Access to resources Recommend Favorite

Proteomic Approach to Biomarker Discovery in Cancer Tissue from Lung Adenocarcinoma Among Nonsmoking Chinese Women in Hong Kong

By Au Joseph   Cho William   Yip Tai-tung   Law Stephen  

Cancer Investigation, Vol. 26, Iss. 2, 2008-02 ,pp. : 128-135

Informa Healthcare

Access to resources Recommend Favorite

Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates

By                                

International Journal of Oncology, Vol. 40, Iss. 3, 2012-01 ,pp. : 825-832

Spandidos Publications

Access to resources Recommend Favorite